{"product_id":"treatment-of-patients-with-advanced-thyroid-cancer-von-jose-manuel-gomez-saez","title":"Treatment of Patients with Advanced Thyroid Cancer","description":"\u003cp\u003eNowadays, thyroid nodules are very frequent as a consequence of the increasing use of diagnostic tools and other not well-known factors as well as the diagnostic evaluation with fine needle aspiration cytology indicated in most thyroid nodules; only 5% of all thyroid nodules are diagnosed as malignant. Only 1% of all epithelial malignancies are thyroid cancer and they represent 95% of all endocrine malignancies. Thus, thyroid cancer is the most frequent endocrine malignancy with 62,980 new cases is expected in 2014 in the United States with an associated rise in mortality [1-3]. Thyroid cancers are divided into four major histological types: papillary (PTC) (85% of cases), follicular (FTC) (11% of cases), medullary (MTC) (3% of cases), and anaplastic thyroid carcinoma (1% of cases). PTC, FTC and MTC thyroid cancers are considered as differentiated thyroid cancer (DTC), which also includes poorly differentiated carcinomas. DTC have a favorable prognosis, however, recurrence or metastasis is observed in 10-15% of patients following the standard treatment of surgery and radioiodine. MTC is a malignancy of the parafollicular C cells of the thyroid.\u003c\/p\u003e\u003cdiv class=\"aw-variant-hidden-subtitle-div\" id=\"aw-variant-subtitle-9786202110556\"\u003e\u003ch3\u003e\u003c\/h3\u003e\u003c\/div\u003e","brand":"Libri","offers":[{"title":"Softcover - 9786202110556","offer_id":39447652106333,"sku":"9786202110556","price":39.9,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0940\/0622\/files\/e3c2626e-42c7-4ac1-ac56-4163594883cc.jpg?v=1775711417","url":"https:\/\/shop.autorenwelt.de\/products\/treatment-of-patients-with-advanced-thyroid-cancer-von-jose-manuel-gomez-saez","provider":"Autorenwelt Shop","version":"1.0","type":"link"}